Wednesday, May 5, 2021

Dr. Kanneganti (St. Jude) presents BI Distinguished Lectureship

1:00 PM to 2:00 PM

Dr. Kanneganti is known for discoveries elucidating functions of innate immune receptors, inflammasomes, and inflammatory cell death. Her work has identified roles for NLRP3, ZBP1, and inflammasomes in infection and inflammation and synergy beneath cell death pathways, establishing the concept of PANoptosis and its implications in infectious,

Monday, May 3, 2021

Dr. Fariba Rezaee, MD (Case Western) presents “Airway Epithelial Barrier Dysfunction by Viruses and Nanoparticles”

2:00 PM to 3:00 PM

Dr. Rezaee’s research lab studies the impact of viral infection and environmental factors on airway epithelial barrier and inflammation. The lab focuses on signaling pathways responsible for the change in the integrity of airway epithelial junctional complexes following RSV infection-an area with many ambiguities. Multiple epidemiologic studies

Monday, April 19, 2021

Webinar: Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

9:00 AM to 10:00 AM

Clinical outcome upon infection with SARS-CoV-2 ranges from silent infection to lethal COVID-19. Qian Zhang and her team identified autosomal-recessive or autosomal-dominant deficiencies of genes in the type I IFN circuit in 23 patients (3.5%) 17 to 77 years of age. She will show that inborn errors of TLR3- and IRF7- dependent type I IFN